JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB18434

Biotin Mouse IgG1, Kappa Monoclonal [MOPC-21] - isotype control

Be the first to review this product! Submit a review

|

(0 Publication)

Biotin Mouse IgG1, Kappa Monoclonal [MOPC-21] - isotype control

View Alternative Names

Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4

  • Unconjugated

    Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control

  • 519 FITC

    FITC Mouse IgG1 kappa [MOPC-21] - Isotype Control

  • 660 APC

    APC Mouse IgG1 kappa [MOPC-21] - Isotype Control

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Mouse IgG1 kappa [MOPC-21] - Isotype Control

  • 695 PerCP/Cy5.5®

    PerCP/Cy5.5® Mouse IgG1, Kappa Monoclonal [MOPC-21] - Isotype Control

  • 785 APC/Cy7®

    APC/Cy7® Mouse IgG1 kappa [MOPC-21] - Isotype Control

  • 778 PE/Cy7®

    PE/Cy7® Mouse IgG1 kappa Isotype Control

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

MOPC-21

Isotype

IgG1

Light chain type

kappa

Conjugation

Biotin

Excitation/Emission
Carrier free

No

Applications

Flow Cyt

applications

Specificity

This clone has unknown specificity and was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed rat and human tissues.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Purification notes
The immunoglobulin was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Storage buffer
pH: 7.2 Preservative: 0.09% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The protein expressed by the IGHG4 gene is part of the constant region of immunoglobulin heavy chains. Immunoglobulins, or antibodies, are glycoproteins produced by B lymphocytes that can be membrane-bound or secreted. During humoral immunity's recognition phase, membrane-bound immunoglobulins act as receptors. When they bind a specific antigen, they trigger B lymphocytes to undergo clonal expansion and differentiate into plasma cells that secrete immunoglobulins. These secreted immunoglobulins then mediate the effector phase of humoral immunity to eliminate the bound antigens. Each immunoglobulin possesses two antigen binding sites, formed by the variable domains of a heavy chain and an associated light chain, allowing for high affinity binding to specific antigens. These variable domains undergo V-(D)-J rearrangement and may experience somatic hypermutations, facilitating affinity maturation after antigen exposure and selection. This supplementary information is collated from multiple sources and compiled automatically.
See full target information IGHG4

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com